441 filings
Page 2 of 23
6-K
CLLS
Cellectis
1 Nov 23
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
1 Nov 23
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
6:44am
20-F/A
2022 FY
CLLS
Cellectis
31 Oct 23
Annual report (foreign) (amended)
5:10pm
6-K
CLLS
Cellectis
31 Oct 23
Current report (foreign)
5:09pm
6-K
CLLS
Cellectis
31 Oct 23
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
24 Oct 23
Cellectis to Present Pre-Clinical Data on HSPC Gene Therapy Program and Comprehensive Analysis of TALE-BE at the ESGCT 30th Annual Congress
4:35pm
6-K
CLLS
Cellectis
12 Oct 23
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
27 Sep 23
Current report (foreign)
4:35pm
6-K/A
CLLS
Cellectis
5 Sep 23
Current report (foreign) (amended)
4:32pm
S-8
CLLS
Cellectis
7 Aug 23
Registration of securities for employees
5:05pm
6-K
CLLS
Cellectis
7 Aug 23
Cellectis Provides Full Report for Second Quarter 2023 Financial Results
4:35pm
6-K
CLLS
Cellectis
7 Aug 23
Current report (foreign)
4:17pm
6-K
CLLS
Cellectis
3 Aug 23
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
4:35pm
6-K
CLLS
Cellectis
27 Jul 23
Current report (foreign)
4:35pm
6-K
CLLS
Cellectis
12 Jul 23
Cellectis Appoints Dr. Cécile Chartier, Ph.D. to its Board of Directors
12:00am
6-K
CLLS
Cellectis
29 Jun 23
Current report (foreign)
8:23am
6-K
CLLS
Cellectis
28 Jun 23
Current report (foreign)
4:57pm
6-K
CLLS
Cellectis
9 Jun 23
Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023
4:35pm
6-K
CLLS
Cellectis
5 Jun 23
Current report (foreign)
4:38pm
SC 13D/A
CBUS
Cibus Inc - Ordinary Shares
1 Jun 23
Cibus / Cellectis ownership change
2:46pm